BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28025726)

  • 1. Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.
    Ranieri R; Starnini G; Carbonara S; Pontali E; Leo G; Romano A; Panese S; Monarca R; Prestileo T; Barbarini G; Babudieri S;
    Infection; 2017 Apr; 45(2):131-138. PubMed ID: 28025726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era.
    Hariri S; Sharafi H; Sheikh M; Merat S; Hashemi F; Azimian F; Tamadoni B; Ramazani R; Gouya MM; Abbasi B; Tashakorian M; Alasvand R; Alavian SM; Poustchi H; Malekzadeh R
    Harm Reduct J; 2020 Oct; 17(1):80. PubMed ID: 33081794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of direct-acting antiviral regimens and telemedicine on the treatment of inmates with hepatitis C virus infection in Israeli prisons.
    Richter V; Goldstein L; Cohen DL; Bermont A; Zelnik Yovel D; Madar M; Rabinovitch R; Shirin H; Broide E
    Sci Prog; 2022; 105(2):368504221105173. PubMed ID: 35722762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy.
    Pontali E; Fiore V; Ialungo AM; Ranieri R; Mollaretti O; Barbarini G; Marri D; Prestileo T; Dell'Isola S; Rastrelli E; Leo G; Starnini G; Babudieri S; Madeddu G;
    Int J Drug Policy; 2018 Sep; 59():50-53. PubMed ID: 29986272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.
    Stöver H; Meroueh F; Marco A; Keppler K; Saiz de la Hoya P; Littlewood R; Wright N; Nava F; Alam F; Walcher S; Somaini L
    BMC Public Health; 2019 Jan; 19(1):30. PubMed ID: 30621658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing assessment and treatment of hepatitis C in the custodial setting.
    Post JJ; Arain A; Lloyd AR
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S70-4. PubMed ID: 23884069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solving the Gap Between HCV Detection and Treatment in Prison HCVRNA Testing and Treatment in a Cohort of Newly Arrived Convicts in Southern Italy.
    Izzo C; Masarone M; Torre P; Melara G; De Matteis G; De Luna A; Pagano AM; Persico M
    Rev Recent Clin Trials; 2021; 16(4):396-402. PubMed ID: 34126911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting.
    Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C;
    Int J Drug Policy; 2020 Mar; 77():102693. PubMed ID: 32045828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).
    Rance J; Lafferty L; Treloar C;
    Harm Reduct J; 2021 Apr; 18(1):46. PubMed ID: 33902595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
    He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
    Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program.
    Masarone M; Caruso R; Aglitti A; Izzo C; De Matteis G; Attianese MR; Pagano AM; Persico M
    Dig Liver Dis; 2020 May; 52(5):541-546. PubMed ID: 32234417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Hepatitis C Cascade of Care in Prisoners-Is There Still Some Work to Do? Analysis of Two Large Penitentiaries in Northern Italy.
    Cambianica A; Marchese V; Pennati F; Faustinelli A; Migliorati M; Roda F; Spinetti A; Zaltron S; Fiorentini S; Caruso A; Quiros-Roldan E; Castelli F; Focà E
    Int J Environ Res Public Health; 2024 Jan; 21(1):. PubMed ID: 38248566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans.
    Beck KR; Kim NJ; Khalili M
    Ann Hepatol; 2018; 17(3):413-418. PubMed ID: 29735789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel.
    Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C;
    Int J Drug Policy; 2021 Dec; 98():103379. PubMed ID: 34311138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How will we manage acute HCV in men having sex with men in the era of all oral therapy?
    Boesecke C; Rockstroh JK
    J Viral Hepat; 2015 Jan; 22(1):2-7. PubMed ID: 25333810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine.
    Morey S; Hamoodi A; Jones D; Young T; Thompson C; Dhuny J; Buchanan E; Miller C; Hewett M; Valappil M; Hunter E; McPherson S
    J Viral Hepat; 2019 Jan; 26(1):101-108. PubMed ID: 30315691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases.
    Gaeta GB; Puoti M; Coppola N; Santantonio T; Bruno R; Chirianni A; Galli M
    Infection; 2018 Apr; 46(2):183-188. PubMed ID: 29238918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of hepatitis C virus in a prison: An 18-year experience.
    Nogales-Garcia M; Parraza Diez N; Vargas Axpe A; Velasco Garcia R; Larrabeiti-Etxebarria A; Roy Lopez-Cano I; Atrio Alvarez I; Lopez de Arcaute Trincado A; Fernandez Lopez de Vicuña EM; Saez de Adana Arroniz E; Martínez Martínez C; Portu Zapirain J
    Enferm Infecc Microbiol Clin (Engl Ed); 2024 May; 42(5):236-241. PubMed ID: 37117143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C Virus Therapy for Decompensated and Posttransplant Patients.
    Dailey F; Ayoub WS
    J Clin Gastroenterol; 2017 Mar; 51(3):215-222. PubMed ID: 28178089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A framework for management of hepatitis C in prisons.
    Spaulding AC; Weinbaum CM; Lau DT; Sterling R; Seeff LB; Margolis HS; Hoofnagle JH
    Ann Intern Med; 2006 May; 144(10):762-9. PubMed ID: 16702592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.